Tower Research Capital LLC (Trc) Poseida Therapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

  • $3.68 Billion
  • Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Poseida Therapeutics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,192 shares of PSTX stock, worth $30,324. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,192
Previous 11,094 71.23%
Holding current value
$30,324
Previous $32,000 71.88%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$2.7 - $4.04 $21,335 - $31,924
-7,902 Reduced 71.23%
3,192 $9,000
Q2 2024

Aug 13, 2024
BUY
$2.0 - $3.46 $8,806 - $15,234
4,403 Added 65.8%
11,094 $32,000
Q1 2024

May 15, 2024
SELL
$2.76 - $4.13 $11,006 - $16,470
-3,988 Reduced 37.34%
6,691 $21,000
Q4 2023

Feb 13, 2024
BUY
$1.83 - $3.51 $10,258 - $19,677
5,606 Added 110.51%
10,679 $35,000
Q3 2023

Nov 14, 2023
SELL
$1.62 - $2.79 $3,061 - $5,273
-1,890 Reduced 27.14%
5,073 $12,000
Q2 2023

Aug 14, 2023
SELL
$1.66 - $3.4 $16,314 - $33,415
-9,828 Reduced 58.53%
6,963 $12,000
Q1 2023

May 09, 2023
BUY
$3.08 - $8.73 $35,235 - $99,871
11,440 Added 213.79%
16,791 $51,000
Q4 2022

Feb 10, 2023
SELL
$3.33 - $6.38 $7,009 - $13,429
-2,105 Reduced 28.23%
5,351 $28,000
Q3 2022

Nov 10, 2022
SELL
$2.43 - $4.51 $1,244 - $2,309
-512 Reduced 6.43%
7,456 $26,000
Q2 2022

Aug 15, 2022
BUY
$1.87 - $5.0 $9,271 - $24,790
4,958 Added 164.72%
7,968 $20,000
Q1 2022

May 12, 2022
BUY
$3.22 - $7.04 $4,591 - $10,039
1,426 Added 90.03%
3,010 $13,000
Q4 2021

Feb 14, 2022
SELL
$6.23 - $7.6 $1,682 - $2,052
-270 Reduced 14.56%
1,584 $11,000
Q3 2021

Nov 15, 2021
SELL
$7.09 - $10.71 $4,438 - $6,704
-626 Reduced 25.24%
1,854 $13,000
Q2 2021

Aug 16, 2021
SELL
$7.96 - $10.07 $4,935 - $6,243
-620 Reduced 20.0%
2,480 $25,000
Q1 2021

May 17, 2021
SELL
$8.51 - $11.91 $12,952 - $18,127
-1,522 Reduced 32.93%
3,100 $30,000
Q4 2020

Feb 16, 2021
BUY
$8.29 - $11.7 $18,039 - $25,459
2,176 Added 88.96%
4,622 $51,000
Q3 2020

Nov 16, 2020
BUY
$8.09 - $16.25 $19,788 - $39,747
2,446 New
2,446 $22,000

Others Institutions Holding PSTX

# of Institutions
105
Shares Held
38.9M
Call Options Held
451K
Put Options Held
146K
View Full List

About Poseida Therapeutics, Inc.

PSTX Quotes by TradingView
  • Ticker PSTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 85,775,600
  • Market Cap $815M
  • Description
  • Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant ...
More about PSTX
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email